Stella Chemifa Corporation (FRA:SLO)
Germany · Delayed Price · Currency is EUR 28.80
+1.00 (3.60%)
At close: Jan 30, 2026
Stella Chemifa Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 36,285 | 36,288 | 30,446 | 35,382 | 37,296 | 32,893 | |
Revenue Growth (YoY) | 6.38% | 19.19% | -13.95% | -5.13% | 13.39% | -2.48% |
Cost of Revenue | 27,790 | 28,031 | 23,999 | 27,972 | 28,394 | 24,680 |
Gross Profit | 8,495 | 8,257 | 6,447 | 7,410 | 8,902 | 8,213 |
Selling, General & Admin | 3,239 | 3,320 | 3,026 | 3,239 | 3,574 | 3,338 |
Research & Development | 597 | 597 | 698 | 660 | 744 | 793 |
Operating Expenses | 3,837 | 3,918 | 3,724 | 3,896 | 4,324 | 4,143 |
Operating Income | 4,658 | 4,339 | 2,723 | 3,514 | 4,578 | 4,070 |
Interest Expense | -51 | -39 | -30 | -32 | -35 | -38 |
Interest & Investment Income | 105 | 109 | 81 | 37 | 13 | 18 |
Earnings From Equity Investments | -379 | -393 | -302 | 329 | 994 | -202 |
Currency Exchange Gain (Loss) | 70 | 102 | 337 | 283 | 102 | -46 |
Other Non Operating Income (Expenses) | 123 | 55 | 121 | 346 | 58 | 221 |
EBT Excluding Unusual Items | 4,526 | 4,173 | 2,930 | 4,477 | 5,710 | 4,023 |
Gain (Loss) on Sale of Investments | - | 263 | 104 | 1,387 | 1,182 | - |
Gain (Loss) on Sale of Assets | 18 | 6 | 17 | 12 | 21 | 15 |
Asset Writedown | -55 | -219 | -487 | -2,509 | -73 | -73 |
Other Unusual Items | - | 1 | 49 | -1 | - | 1 |
Pretax Income | 4,489 | 4,224 | 2,613 | 3,366 | 6,840 | 3,966 |
Income Tax Expense | 1,585 | 1,352 | 777 | 1,383 | 1,814 | 1,262 |
Earnings From Continuing Operations | 2,904 | 2,872 | 1,836 | 1,983 | 5,026 | 2,704 |
Minority Interest in Earnings | 25 | 20 | 9 | 297 | 338 | 255 |
Net Income | 2,929 | 2,892 | 1,845 | 2,280 | 5,364 | 2,959 |
Net Income to Common | 2,929 | 2,892 | 1,845 | 2,280 | 5,364 | 2,959 |
Net Income Growth | 21.18% | 56.75% | -19.08% | -57.49% | 81.28% | 53.79% |
Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 13 | 13 |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 13 | 13 |
Shares Change (YoY) | -1.18% | -0.18% | -1.93% | -3.33% | -1.12% | -0.67% |
EPS (Basic) | 246.36 | 240.96 | 153.44 | 185.97 | 422.93 | 230.69 |
EPS (Diluted) | 246.36 | 240.96 | 153.44 | 185.97 | 422.93 | 230.69 |
EPS Growth | 22.63% | 57.04% | -17.49% | -56.03% | 83.34% | 54.83% |
Free Cash Flow | 3,725 | 2,950 | 841 | 1,048 | 2,701 | 4,961 |
Free Cash Flow Per Share | 313.31 | 245.79 | 69.94 | 85.48 | 212.96 | 386.76 |
Dividend Per Share | 170.000 | 170.000 | 154.000 | 60.000 | 60.000 | 47.000 |
Dividend Growth | -5.03% | 10.39% | 156.67% | - | 27.66% | 4.44% |
Gross Margin | 23.41% | 22.75% | 21.18% | 20.94% | 23.87% | 24.97% |
Operating Margin | 12.84% | 11.96% | 8.94% | 9.93% | 12.28% | 12.37% |
Profit Margin | 8.07% | 7.97% | 6.06% | 6.44% | 14.38% | 9.00% |
Free Cash Flow Margin | 10.27% | 8.13% | 2.76% | 2.96% | 7.24% | 15.08% |
EBITDA | 7,509 | 7,151 | 5,491 | 6,107 | 7,291 | 7,109 |
EBITDA Margin | 20.70% | 19.71% | 18.04% | 17.26% | 19.55% | 21.61% |
D&A For EBITDA | 2,851 | 2,812 | 2,768 | 2,593 | 2,713 | 3,039 |
EBIT | 4,658 | 4,339 | 2,723 | 3,514 | 4,578 | 4,070 |
EBIT Margin | 12.84% | 11.96% | 8.94% | 9.93% | 12.28% | 12.37% |
Effective Tax Rate | 35.31% | 32.01% | 29.74% | 41.09% | 26.52% | 31.82% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.